Induction of an antitumor immunological response by an intratumoral injection of dendritic cells pulsed with genetically engineered Semliki Forest virus to produce interleukin-18 combined with the systemic administration of interleukin-12.

Source:http://linkedlifedata.com/resource/pubmed/id/14567611

Download in:

View as

General Info

PMID
14567611